Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-03 Sale | 2023-04-05 4:33 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer | 7,000 | $8.29 | $58,030 | 207,275 (Direct) | View |
| 2023-02-01 Sale | 2023-02-02 5:20 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO | 100,000 | $10.38 | $1,038,000 | 1,018,739 (Indirect Direct) | View |
| 2022-12-15 Sale | 2022-12-19 5:09 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO | 14,100 | $10.9 | $153,690 | 897,730 (Indirect Direct) | View |
| 2022-12-15 Sale | 2022-12-19 4:58 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer | 3,125 | $10.89 | $34,031 | 133,275 (Direct) | View |
| 2022-12-15 Sale | 2022-12-19 4:55 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer | 5,700 | $10.9 | $62,130 | 163,966 (Direct) | View |
| 2022-12-15 Sale | 2022-12-19 4:48 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer | 6,100 | $10.9 | $66,490 | 211,610 (Direct) | View |
| 2022-12-15 Sale | 2022-12-19 4:45 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 445 | $10.9 | $4,851 | 10,753 (Direct) | View |
| 2022-12-15 Sale | 2022-12-19 4:38 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Chief Legal Officer | 4,175 | $10.88 | $45,424 | 198,770 (Direct) | View |
| 2022-12-01 Sale | 2022-12-02 6:36 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 8,600 | $13.01 | $111,886 | 11,198 (Direct) | View |
| 2022-12-01 Sale | 2022-12-02 6:33 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO | 297,573 | $12.94 | $3,851,918 | 994,486 (Indirect Direct) | View |
| 2022-11-14 Sale | 2022-11-16 4:19 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer | 31,515 | $13.88 | $437,428 | 298,541 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-31 Option Award | 2023-06-02 4:36 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director | 680 | $8.27 | 32,506 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 4:34 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | LEVIN ALAN G Director | 1,360 | $8.27 | 20,345 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 4:32 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director | 680 | $8.27 | 32,369 (Direct) | View |
| 2023-03-21 Exercise | 2023-03-23 4:40 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO | 31,055 | $3.22 | 1,365,789 (Direct) | View |
| 2023-03-21 Exercise | 2023-03-23 4:40 pm | 2017-05-23 2026-05-23 | BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO | 31,055 | $0 | 1,365,789 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 4:44 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director | 635 | $8.85 | 31,826 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 4:41 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | INGRAM ROBERT ALEXANDER Director | 2,259 | $8.85 | 100,198 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 4:38 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director | 635 | $8.85 | 31,689 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 4:37 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | LEVIN ALAN G Director | 1,271 | $8.85 | 18,985 (Direct) | View |
| 2022-12-29 Gift | 2023-02-02 5:20 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO | 15,000 | $0 | 1,018,739 (Direct) | View |
| 2023-02-01 Exercise | 2023-02-02 5:20 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO | 100,000 | $5.45 | 1,018,739 (Direct) | View |
| 2023-02-01 Exercise | 2023-02-02 5:20 pm | N/A 2023-08-08 | BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO | 100,000 | $0 | 1,018,739 (Direct) | View |
| 2023-01-31 Exercise | 2023-02-02 5:15 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | LEE KENNETH B JR Director | 15,000 | $1.71 | 52,118 (Direct) | View |
| 2023-01-31 Exercise | 2023-02-02 5:15 pm | 2013-06-30 2023-05-31 | BIOCRYST PHARMACEUTICALS INC | BCRX | LEE KENNETH B JR Director | 15,000 | $0 | 52,118 (Direct) | View |
| 2022-12-19 Option Award | 2022-12-21 4:43 pm | 2023-12-19 2032-12-19 | BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Chief Legal Officer | 192,500 | $0 | 391,270 (Direct) | View |
| 2022-12-19 Option Award | 2022-12-21 4:41 pm | 2023-12-19 2032-12-19 | BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer | 319,000 | $0 | 452,275 (Direct) | View |
| 2022-12-19 Option Award | 2022-12-21 4:38 pm | 2023-12-19 2032-12-19 | BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO | 722,500 | $0 | 1,620,230 (Direct) | View |
| 2022-12-19 Option Award | 2022-12-21 4:36 pm | 2023-12-19 2032-12-19 | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 14,400 | $0 | 25,153 (Direct) | View |
| 2022-12-19 Option Award | 2022-12-21 4:34 pm | 2023-12-19 2032-12-19 | BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer | 192,500 | $0 | 404,110 (Direct) | View |
| 2022-12-19 Option Award | 2022-12-21 4:32 pm | 2023-12-19 2032-12-19 | BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer | 192,500 | $0 | 356,466 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-02 6:36 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 8,600 | $1.42 | 11,198 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-02 6:36 pm | 2014-01-01 2023-01-01 | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 8,600 | $0 | 11,198 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-02 6:33 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO | 297,573 | $1.42 | 994,486 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-02 6:33 pm | 2014-01-01 2023-01-01 | BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO | 297,573 | $0 | 994,486 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 6:30 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director | 421 | $13.36 | 31,054 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 6:28 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director | 421 | $13.36 | 31,191 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 6:26 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | LEVIN ALAN G Director | 842 | $13.36 | 17,714 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 6:24 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | INGRAM ROBERT ALEXANDER Director | 1,497 | $13.36 | 97,939 (Direct) | View |
| 2022-11-14 Exercise | 2022-11-16 4:19 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer | 50,000 | $1.42 | 298,541 (Direct) | View |
| 2022-11-14 Exercise | 2022-11-16 4:19 pm | 2014-01-01 2023-01-01 | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer | 100,000 | $0 | 298,541 (Direct) | View |
| 2022-08-31 Option Award | 2022-09-02 4:36 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director | 404 | $13.9 | 30,770 (Direct) | View |
| 2022-08-31 Option Award | 2022-09-02 4:34 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | LEVIN ALAN G Director | 809 | $13.9 | 16,872 (Direct) | View |
| 2022-08-31 Option Award | 2022-09-02 4:31 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | INGRAM ROBERT ALEXANDER Director | 1,438 | $13.9 | 96,442 (Direct) | View |
| 2022-08-31 Option Award | 2022-09-02 4:29 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director | 404 | $13.9 | 30,633 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 4:53 pm | 2023-06-07 2032-06-07 | BIOCRYST PHARMACEUTICALS INC | BCRX | SANDERS MACHELLE Director | 42,888 | $0 | 42,888 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 4:51 pm | 2023-06-07 2032-06-07 | BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director | 42,888 | $0 | 60,388 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 4:50 pm | 2023-06-07 2032-06-07 | BIOCRYST PHARMACEUTICALS INC | BCRX | INGRAM ROBERT ALEXANDER Director | 42,888 | $0 | 125,026 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 4:48 pm | 2023-06-07 2032-06-07 | BIOCRYST PHARMACEUTICALS INC | BCRX | Hutson Nancy J Director | 42,888 | $0 | 107,961 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 4:46 pm | 2023-06-07 2032-06-07 | BIOCRYST PHARMACEUTICALS INC | BCRX | McKee Amy E Director | 42,888 | $0 | 42,888 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 4:45 pm | 2023-06-07 2032-06-07 | BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director | 42,888 | $0 | 60,251 (Direct) | View |